Clinical Research Advantage Receives Silver Best in Biz Award for Executive Team of the Year

TEMPE, Ariz.--(BUSINESS WIRE)--Clinical Research Advantage (CRA) received a national honor in this year’s Best in Biz Awards, the only independent business awards program judged by members of the press and industry analysts. CRA received the Silver Award for Executive Team of the Year.

“We are honored to receive this level of recognition from the Best in Biz Awards.”

Mark S. Hanley, Chief Executive Officer, and David Bruggeman, President and Chief Operating Officer, were recognized for their strategic vision and leadership in growing the company to become the largest and most therapeutically diverse integrated site network in the clinical trials industry.

“2012 has been an exciting year for Clinical Research Advantage. This year, the company expanded its operations while forging innovative partnerships that will continue to improve the quality of clinical trials,” said Bruggeman. “We are honored to receive this level of recognition from the Best in Biz Awards.”

More than 400 entries were received in this year’s awards program, from a wide array of public and private companies of all sizes and from a variety of industries and regions in the U.S. and Canada.

Winners of Best in Biz Awards 2012 were determined by an independent panel of 32 judges from top-tier news, business and technology publications, as well as broadcast outlets and analyst firms, such as ABC, Businessweek, Computerworld, ECT News Network, Entrepreneur, eWeek, Examiner, Financial Times, Forbes, FOX News, Hartford Business Journal, IDG Ventures, IEEE Institute, Inc., Insight Media, King Features Syndicate, Lab Reviews, Network World, The News and Observer, PC Magazine, ReadWriteWeb, South Florida Business Journal, Tech-Gaming, Techtalk, Upstart Business Journal, USA Today and ZDNet.

About Clinical Research Advantage

Tempe, Arizona-based Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations. As a leading trial management organization, CRA operates from 38 sites across 17 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and efficiently. Founded in 1992, CRA has successfully completed more than 1,800 clinical trials on behalf of its clients. For more information, please visit www.crastudies.com.